MedTrace Logo

A Clinical Study Assessing the Potential of Piboserod for the Treatment of Heart Failure

NCT00421746 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2007-08-03

No results posted yet for this study

Summary

The purpose of this study is to determine whether piboserod, a serotonin-4 receptor antagonist, is effective for the treatment of patients with congestive heart failure.

Conditions

  • Congestive Heart Failure

Interventions

DRUG

Piboserod

Sponsors & Collaborators

  • Smerud Medical Research International AS

    collaborator OTHER

  • Bio-Medisinsk Innovasjon

    lead INDUSTRY

Principal Investigators

  • Christian Torp-Pedersen, Dr. Med · Bispebjerg Hospital, Copenhagen, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Completion
2007-07-31

Countries

  • Denmark
  • Norway
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00421746 on ClinicalTrials.gov